Organized in 1956, Forest Laboratories Inc. (FRX) is a pharmaceutical corporation focused on the in-licensing drugs for development. Its products include those developed by it and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. Forest and it subsidaries develop, manufacture and sell branded forms of ethical drug products, most of which are only available with written instructions from a physician. Forest emphasizes detailing to physicians of those branded ethical drugs that have the most potential for growth and benefit for patients. The company mainly sells its drugs in the U.S., but has a small international presence.
Forest also has well-established franchises in therapeutic areas of the central nervous, cardiovascular and respiratory systems, as well as R&D (research and development) programs addressing a great range of health conditions. Last fiscal year, the company posted total revenues of $3.1 billion, down 31.8%, mostly due to the loss exclusivity on the antidepressant Lexapro and the massive hole that left. Continue Reading »